2022 International Congress Archives - Page 134 of 153

Balance evaluation in Parkinson’s disease using a set of simple tests

K. Krzysztoń, J. Stolarski, A. Poznańska, J. Kochanowski (Warsaw, Poland)
Ballet for Parkinson’s disease, a new concept: Remote delivery via the English National Ballet’s Dance for Parkinson’s programme

A. Podlewska, R. Davis, L. Batzu, P. Tall, F. Derbyshire-Fox, A. Hartley, N. Sevdalis, A. Woods, K. Ray Chaudhuri (London, United Kingdom)
Basal forebrain contribution to cognitive deficits during medication “off” state in Parkinson’s disease

D. Lench, T. Turner, E. Woolbright, F. Rodriguez-Porcel, G. Revuelta (Charleston, USA)
Baseline Characteristics and Treatment Patterns of a Global Huntington Disease Population Stratified by Chorea Severity

V. Sung, E. Furr Stimming, S. Reshef, R. Willock, R. Ribalov, S. Brighton, S. Leo (Birmingham, USA)
BBP-671, AN INVESTIGATIONAL MODULATOR OF PANTOTHENATE KINASES, DEMONSTRATES PROOF OF CONCEPT IN A PKAN MOUSE MODEL AND TARGET ENGAGEMENT IN HUMANS

D. Gretler, A. Jurecka, R. Sukhun, C. Henry, A. Wade, M. Harden, C. Subramanian, M. Frank, R. Lee, C. Rock, S. Jackowski, S. Rao, U. Sinha (San Francisco, USA)
Beliefs about Tourette Syndrome in Adolescent Patients with Tics

J. Frey, T. Tholanikunnel, L. Kugler, M. Wajid, H. Simpson, I. Malaty (Gainesville, USA)
Belly Dance Dyskinesia, a manifestation of B12 deficiency and hyperhomocysteinuria in MTHFR gene mutation. Videographic record of a case.

D. López Domínguez, B. Solano Vila, A. Cots Foraster (Girona, Spain)
Beneficial effects of cinnamaldehyde in orofacial dyskinesia in haloperidol-induced rat model

S. -, V. Parcha (Dehardun, India)
Benefit of multiple incobotulinumtoxinA injections for pain reduction in adult patients with limb spasticity: an analysis of pooled data from phase 2 and 3 studies

J. Wissel, A. Camões-Barbosa2, G. Comes, M. Althaus, A. Scheschonka, D. Simpson (Potsdam, Germany)
Benefits and Risks of Staged Bilateral versus Unilateral VIM DBS for Essential Tremor

P. Prakash, G. Deuschl, S. Ozinga, K. Mitchell, B. Cheeran, P. Larson, A. Merola, S. Groppa, T. Tomlinson, J. Ostrem (SAN FRANCISCO, USA)
Beta-agonists and risk of Parkinson’s disease: Meta-analysis of real-world evidence studies

A. Singh, S. Hussain, B. Antony (Hobart, Australia)
Beyond the subthalamic nucleus: tractography patterns of Magnetic Resonance-guided Focused Ultrasound subthalamotomy

R. Rodriguez-Rojas, JU. Mañez-Miro, JA. Pineda-Pardo, R. Martinez-Fernandez, M. Del Alamo, JA. Obeso (Madrid, Spain)
Bilateral Globus Pallidus interna Deep Brain Stimulation for the treatment of chorea-acanthocytosis: A case report from South Africa

M. Smith, G. Jonsson, A. Ferreira-Correia, N. Duff, M. Zorio (Johannesburg, South Africa)
Bilateral GPi DBS for the treatment of a general dystonia with EIF2AK2 mutant: Report of globus pallidus local field potentials and the therapeutic outcome

CC. Chen, TC. Liu, PH. Tu, CH. Yeh, MC. Yeap, PL. Chen, CS. Lu, CC. Chen (Taoyuan City, Taiwan)
Bilateral Magnetic Resonance Imaging-Guided Focused Ultrasound Thalamotomy in Medication-Resistant Essential Tremor Treatment.

O. Kachemaeva, R. Galimova, D. Krekotin, Y. Sidorova, N. Mukhamadeeva, G. AKHMADEEVA. (Ufa, Russian Federation)
Binaural acoustic stimulation reduces tremor severity in patients suffering from Parkinson’s disease

A. Calvano, L. Timmermann, C. Oehrn, I. Weber (Marburg, Germany)
Biochemical markers of glucocerebrosidase (GCase) deficiency in primary macrophages derived from GBA1 mutation carriers with and without Parkinson’s disease

S. Pchelina, A. Kopytova, M. Nikolaev, A. Emelyanov, G. Baydakova, T. Usenko, A. Izymchenko, D. Bogdanova, K. Senkevich, I. Miliukhina, Y. Zakharova (Gatchina, Russian Federation)
Biomarker based on natural language processing methods to detect the stages of Parkinson’s disease through electroencephalography

A. Maitin, J. Morales, S. Romero-Azpitarte, J. Romero, A. Arroyo Ferrer, Y. González Zamorano, F. Sánchez Cuesta, A. García-Tejedor (Pozuelo de Alarcón, Spain)
BIOMARKERS OF PARKINSONISM AND POSSIBILITIES OF PREDICTION OF THE COURSE OF PARKINSON’S DISEASE

D. Akramova, K. Daminova (Tashkent, Uzbekistan)
Bis(monoacylglycerol) phosphate levels are elevated at baseline in carriers of pathogenic variants in LRRK2 and GBA1 and do not predict progression of PD in PPMI cohorts

K. Merchant, T. Simuni, J. Fedler, M. Brumm, C. Caspell, E. Tangstrandt, F. Hsieh, K. Nudelman, T. Foroud, C. Coffey, A. Siderowf, C. Tanner, K. Marek, P. Investigators (Chicago, USA)
Bitopertin, a GlyT1 inhibitor, attenuates the development of dyskinesia in the 6-OHDA-lesioned rat

I. Frouni, W. Kang, D. Bédard, S. Belliveau, C. Kwan, A. Hamadjida, P. Huot (Montreal, Canada)
Blaming neuromelanin for Parkinson’s disease: time-dependent tyrosinase overexpression drives endogenous synucleinopathy in non-human primates

J. Lanciego, J. Chocarro, A. Fajardo-Serrano, A. Vazquez, AI. Rodriguez-Perez, J. Labandeira-Garcia, M. Vila, A. Rico (Pamplona, Spain)
Blood biomarkers and their association with non-motor symptoms in early Parkinson’s Disease

J. Kaur, S. Ng, N. Chia, X. Deng, J. Tan, X. Choi, D. Heng, Z. Xu, K. Tay, W. Au, A. Ng, E. Tan, L. Tan (central, Singapore)
Blood Lipid Biomarkers in Early Parkinson Disease and Parkinson Disease with Mild Cognitive Impairment

DX. Deng, LT. Tan (Singapore, Singapore)
Blood microRNA-7 as a Progression Biomarker in Parkinson’s disease

M. Doursout, C. Adams, J. Suescun, K. Block, E. Tharp, T. Ellmore, M. Schiess (Houston, USA)
Blood neurofilament light chain as a biomarker of Parkinson’s disease

S. Ganesh, B. Huxford, A. Zirra, C. Edwards, C. Simonet, T. Haque, D. Gallagher, C. Budu, R. Dobson, A. Noyce (London, United Kingdom)
Blood-derived α-synuclein from Parkinson´s disease patients is able to seed pathology

A. Kluge, J. Bunk, E. Schäffer, H. Knacke, A. Drobny, W. Xiang, R. Lucius, P. Arnold, F. Zunke, D. Berg (Kiel, Germany)
Body Image Scale in Functional Movement Disorders; A Comparative Study

M. Balal, M. Demirkiran (Adana, Turkey)
Body-first and brain-first PD animal models mimic human PD subtypes

N. Vanden Berge, M. Pedersen, I. Klæstrup, J. Jacobsen, M. Simonsen, A. Alstrup, M. Romero-Ramos, P. Borghammer (Aarhus N, Denmark)
Boostering motor imagery processing to improve gait in patients with Parkinson disease and freezing of gait: a preliminary study

S. Mezzarobba, E. Ravizzotti, P. Bernardis, M. Putzolu, C. Cosentino, A. Botta, G. Bonassi, R. Marchese, L. Avanzino, E. Pelosin (Genoa, Italy)
Botulinum neurotoxin simulation workshop: Impact on resident satisfaction and knowledge

C. Selvadurai, E. Cournean, N. Prakash, B. Rodrigues (Farmington, USA)
Botulinum Toxin A in the Management of peripheral mononeuropathy: post herpetic neuralgia and trigeminal neuralgia

F. Ortega (guatemala, Guatemala)
Botulinum toxin injections are an effective treatment for patients with essential head tremor.

A. Marques, I. Rieu, B. Pereira, G. Castelnovo, F. Fluchère, C. Laurencin, B. Degos, A. Poujois, A. Kreisler, S. Sangla, M. Tir, I. Benatru, G. Blanchet-Fourcade, D. Guehl, D. Gayraud, L. Tatu, C. Tranchant, D. Amarantini, M. Simonetta, F. Durif (Clermont-Ferrand, France)
Botulinum Toxin Outcomes in Patients with Lower Limb Dystonia

M. Wajid, J. Frey, L. Kugler, T. Stiep, J. Yu, J. Toledo, J. Lopes, A. Ramirez-Zamora, A. Rawls, A. Wagle Shukla, I. Malaty (Gainesville, USA)
Botulinum Toxin Therapy for Medication and DBS Refractory Foot Dystonia of Parkinsonism

E. Zinoviev, M. Ganapathy, M. Siddiqui (Winston-Salem, USA)
Brain effects of high-intensity exercise on the dopamine system in individuals with Parkinson’s disease

S. Tinaz, B. de Laat, G. Stanley, J. Hoye, J. Key, M. Hespeler, J. Ligi, Y. Huang, N. Nabulsi, E. Morris (New Haven, USA)
Brain glia activation and peripheral inflammation in Parkinson’s disease: a PET study

SY. Liu, HW. Qiao, TB. Song, O. Barret, FW. Qiao, XL. Liu, X. Xu, YN. Cai, G. Tamagnan, V. Sossi, P. Chan (Beijing, China)
BRAIN REGIONAL HYPOMETABOLISM PROGRESSION IN iRBD: THE COGNITIVE ROLE OF OCCIPITAL HYPOMETABOLISM

G. Carli, S. Meles, A. Janzen, D. Perani, W. Oertel, K. Leenders (Groningen, Netherlands)
Brain structure alternations and disrupted functional connectivity in paroxysmal kinesigenic dyskinesia

Y. Liu, C. Chen, P. Wang, Y. Chen, C. Lin, S. Kwan, C. Chou, D. Yen, Y. Wu (北投區, Taiwan)
BRAT1 associated neurodegeneration and review of literature

V. Cerino Palomino, T. Ortegano Briones, D. Tristán Samaniego, C. Zepeda Salazar, C. Torres Vázquez, R. Abundes Corona, G. Cervantes Arriaga, M. Rodríguez Violante (Mexico City, Mexico)
Bullous skin lesions following introduction of safinamide in a woman with Parkinson’s disease

L. Lachance, P. Huot (Montreal, Canada)
Burden of COVID-19 among patients with Parkinson’s disease and associated clinical outcomes: Evidence from a meta-analysis

S. Hussain (Brno, Czech Republic)